Biosensors International group Ltd (BSNRF/BSNRF.PK) Wrap Up:

Biosensors International Group, Ltd., an investment holding company, engages in the development, manufacture, and sale of medical devices used in interventional cardiology and critical care procedures. Its interventional cardiology products include Axxion drug-eluting stent, a non-polymeric Paclitaxel drug-eluting stent system, which is used to navigate the coronary vaculature, facilitate implanation, and deliver the drug safely; and BioMatrix, which is mounted on a delivery system that enables access to various lesions and vessel physiologies. The company also offers PTCA Balloon Catheters, including Vigor 2, a dilatation catheter; Concerto, OTW catheter for alcohol ablation of the septal artery, which is used for the treatment of Hypertrophic Obstructive Cardiomyopathy; Senso, a stent carrier and dilatation catheter; and Powerline, a PTCA catheter that provides trackability for tortuous vessels and crossability for tight lesions. In addition, it offers S-Stent, Calix, Nexus, Nexus II, and Gazelle bare metal coronary stents; and Transito guidewire. The company?s critical care products include Biotrans II Transducer Kits, a disposable/reusable blood pressure transducer system; Multi-Lumen Central Venous Catheter that is used with straight introducer and Y-Valve needles; Bipolar Pacing Catheter for temporary transvenous cardiac pacing; Accutrans disposable blood pressure transducers; Thermodilution and Pulmonary Artery Catheters for pulmonary artery monitoring; Embolectomy Catheter for easy arterial insertion; and Biotray that provides the benefits of the Safety Wedge thermodilution/pulmonary artery catheter. Further, it sublicenses proprietary medical technology. The company was founded in 1990 and is based in Singapore, Singapore.